Jones Financial Companies
DXCM icon

Jones Financial Companies’s DexCom DXCM Stock Holding History

Jones Financial Companies’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Sell
30,697
-5,397
-15% -$360K ﹤0.01% 1547
2026
Q1 		$2.25M Buy
36,094
+19,887
+123% +$1.38M ﹤0.01% 1381
2025
Q4 		$1.08M Buy
16,207
+166
+1% +$10.7K ﹤0.01% 1198
2025
Q3 		$1.08M Buy
16,041
+508
+3% +$40.2K ﹤0.01% 1104
2025
Q2 		$1.34M Buy
15,533
+2,485
+19% +$195K ﹤0.01% 893
2025
Q1 		$884K Buy
13,048
+2,132
+20% +$174K ﹤0.01% 907
2024
Q4 		$849K Buy
10,916
+3,291
+43% +$244K ﹤0.01% 800
2024
Q3 		$513K Buy
7,625
+881
+13% +$72.3K ﹤0.01% 810
2024
Q2 		$765K Buy
6,744
+4,338
+180% +$548K ﹤0.01% 467
2024
Q1 		$334K Buy
2,406
+2,224
+1,222% +$280K ﹤0.01% 385
2023
Q4 		$22.6K Buy
+182
New +$18.6K ﹤0.01% 571
2023
Q1 		– Sell
-20
Closed -$2K – 629
2022
Q4 		$2K Buy
+20
New +$2.2K ﹤0.01% 598

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jones Financial Companies's DXCM Position: Q2 2026 in Review

Jones Financial Companies reduced its DexCom (DXCM) stake by 15% in Q2 2026, selling an estimated $360K and leaving 30,697 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Jones Financial Companies first reported a position in DXCM in Q4 2022 and has held it in 12 quarters since. The position peaked at $2.25M in Q1 2026. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Jones Financial Companies held 30,697 shares of DexCom worth $2.15M as of Q2 2026.
  • Jones Financial Companies sold 5,397 DexCom shares in Q2 2026, an estimated $360K.
  • DexCom made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1547 holding.
  • Jones Financial Companies first reported a position in DexCom in Q4 2022 and has held it in 12 quarters since.
  • Jones Financial Companies's DexCom position peaked at $2.25M in Q1 2026.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.